只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-17 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 3,656 | US$37.90 | US$138,562.40 | 298,901 | SEC |
| 2026-07-16 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 9,163 | US$36.46 | US$334,082.98 | 308,441 | SEC |
| 2026-07-16 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 5,865 | US$37.26 | US$218,529.90 | 302,576 | SEC |
| 2026-07-16 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 19 | US$37.96 | US$721.24 | 302,557 | SEC |
| 2026-07-15 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 7,155 | US$36.16 | US$258,724.80 | 338,904 | SEC |
| 2026-07-15 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 7,845 | US$37.04 | US$290,578.80 | 331,059 | SEC |
| 2026-07-15 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 4,465 | US$36.00 | US$160,740.00 | 326,594 | SEC |
| 2026-07-15 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 8,972 | US$36.99 | US$331,874.28 | 317,622 | SEC |
| 2026-07-15 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 18 | US$37.54 | US$675.72 | 317,604 | SEC |
| 2026-05-11 2026-05-12 | DUK Duke Energy CORP | Renjel Louis E. Officer · EVP&CEO DEF&MW&ChiefCorpAffOff | 卖出（S） | 3,500 | US$125.15 | US$438,025.00 | 21,415 | SEC |
| 2026-05-07 2026-05-11 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 4,321 | US$28.52 | US$123,234.92 | 346,176 | SEC |
| 2026-05-07 2026-05-11 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 117 | US$29.10 | US$3,404.70 | 346,059 | SEC |
| 2026-05-06 2026-05-06 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 8,152 | US$28.04 | US$228,582.08 | 366,397 | SEC |
| 2026-05-06 2026-05-06 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 15,900 | US$29.13 | US$463,167.00 | 350,497 | SEC |
| 2026-05-05 2026-05-06 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 9,645 | US$28.12 | US$271,217.40 | 375,480 | SEC |
| 2026-05-05 2026-05-06 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 931 | US$29.00 | US$26,999.00 | 374,549 | SEC |
| 2026-05-04 2026-05-06 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 9,180 | US$27.50 | US$252,450.00 | 391,597 | SEC |
| 2026-05-04 2026-05-06 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 5,460 | US$28.37 | US$154,900.20 | 386,137 | SEC |
| 2026-05-04 2026-05-06 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 312 | US$29.56 | US$9,222.72 | 385,825 | SEC |
| 2026-05-04 2026-05-06 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 700 | US$30.08 | US$21,056.00 | 385,125 | SEC |
| 2026-04-16 2026-04-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 881 | US$27.49 | US$24,218.69 | 400,777 | SEC |
| 2026-04-16 2026-04-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 288 | US$27.01 | US$7,778.88 | 401,658 | SEC |
| 2026-04-15 2026-04-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 2,044 | US$26.84 | US$54,860.96 | 401,946 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| FOFO | 7,503 | 0 | 9,816.4584 | 76.43% | Q, N |
| FOF | 27,025.32 | 0 | 39,413.4275 | 68.57% | Q, N |